Evidence map›Paper›PMID 41234193›Full record

ArticleEuro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin2025

Emergence of vancomycin-resistant

Danielle Vuichard-Gysin, Andrea C Büchler, Dominique S Blanc, Peter M Keller, Pascal Schläpfer, Andreas Kronenberg, Vanja Piezzi, Patrice Nordmann, Laurence Senn, Stephan Harbarth and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Vancomycin-resistant Enterococcus faecium: a national wide genomic snapshot in Switzerland.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2026
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Danielle Vuichard-GysinSwiss National Centre for Infection Prevention, Swissnoso, Bern, Switzerland.
Andrea C BüchlerSwiss National Centre for Infection Prevention, Swissnoso, Bern, Switzerland.
Dominique S BlancInfection Prevention and Control Unit, Infectious Diseases Service, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
Peter M KellerClinical Bacteriology and Mycology, University Hospital Basel, Basel, Switzerland.
Pascal SchläpferLaboratory Medicine, University Hospital Basel, Basel, Switzerland.
Andreas KronenbergInstitute for Infectious Diseases, University of Bern, Bern, Switzerland.
Vanja PiezziFederal Office of Public Health, Bern, Switzerland.
Patrice NordmannNational Reference Centre for Emerging Antibiotic Resistance (NARA), Fribourg, Switzerland.
Laurence SennSwiss National Centre for Infection Prevention, Swissnoso, Bern, Switzerland.
Stephan HarbarthSwiss National Centre for Infection Prevention, Swissnoso, Bern, Switzerland.
Sarah Tschudin-SutterSwiss National Centre for Infection Prevention, Swissnoso, Bern, Switzerland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We describe the emergence of vancomycin-resistant

Indexed as

Anti-Bacterial AgentsCarbon-Oxygen LigasesCross InfectionDaptomycinDisease OutbreaksEnterococcus faeciumGram-Positive Bacterial InfectionsVancomycin-Resistant EnterococciAdultAgedBacterial ProteinsFemaleHumansMaleMicrobial Sensitivity TestsMiddle AgedAnti-Bacterial AgentsBacterial ProteinsCarbon-Oxygen LigasesDaptomycinVancomycindaptomycin non susceptibilityemergenceoutbreakrisk factorST612VRE

Identifiers

PMID41234193
PMCPMC12633707

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.